Following the success of our International Spatial Biology Congress: Europe for the last 2 years, we are delighted to be hosting a Spatial Biology event in America. In this rapidly developing field, spatial biology provides significant potential for creating novel clinical insights. Recent technological advancements in spatial biology have provided insights into new strategies to prevent and treat disease, particularly the interactions between the tumour and the tumour microenvironment in cancers to target patients to more specific treatments. New spatial research has focused more on the analysis of the transcriptome, epigenome, and metabolomics as well as gene and protein expression to discover how these influence cellular and molecular distributions and interactions.

With a single track over two days, featuring more than 30 presentations, you will discover the latest developments in spatial omics and techniques, bioinformatics, and spatial biology data analysis, as well as the application of spatial biology to disease and drug development. There will also be a dynamic exhibition room filled with providers showcasing their spatial technologies with ample networking opportunities, an interactive panel discussion, roundtables, and a poster competition.